LEXINGTON, Mass., July 21, 2019 – Shares of Agenus Inc. (NASDAQ: AGEN) declined -2.77% to $2.46. The stock grabbed the investor’s attention and traded 826.999K shares as compared to its average daily volume of 1.01M shares. The stock’s institutional ownership stands at 33.70%.
Agenus Inc. (AGEN) reported first-quarter net income of $17.40M, after reporting a loss in the same period a year earlier. The Lexington, Massachusetts-based company said it had net income of 12 cents per share. The biotechnology company posted revenue of $8.60M in the period.
AGEN has a market value of $330.26M while its EPS was booked as $-0.80 in the last 12 months. The stock has 134.25M shares outstanding. In the profitability analysis, the company has net profit margin of -75.80%. Beta value of the company was 1.86; beta is used to measure riskiness of the security. Analyst recommendation for this stock stands at 1.30.
I am the driving force behind Digital Market News with a vision to broaden the company’s readership throughout 2016. I am an editor and reporter of “Healthcare” category.
Address: 1091 Stratford Park, St Meinrad, IN 47577, USA
Phone: (+1) 812-836-1428
Latest posts by Ron Barnett (see all)
- An Eye on Financial Results: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) - November 12, 2019
- Brief Overview on Company’s Performance: Athersys Inc. (NASDAQ: ATHX) - July 29, 2019
- Featured Earnings Report: Aduro BioTech Inc. (NASDAQ: ADRO) - July 26, 2019